Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IGI Laboratories, Inc reaffirms FY 2014 revenue guidance

Tuesday, 29 Apr 2014 04:05pm EDT 

IGI Laboratories, Inc:Expects FY 2014 revenue to increase between 40 pct and 45 pct over FY 2013.Reported revenue of $18.2 million in FY 2013.FY 2014 revenue of $27.6 million - Thomson Reuters I/B/E/S. 

Company Quote

0.13 +1.43%
26 Dec 2014